Efficacy/effectiveness Newborn (0-1 years) Children (2-9 years) Rotavirus
Efficacy/effectiveness Newborn (0-1 years) Children (2-9 years) Rotavirus
Efficacy/effectiveness Safety Newborn (0-1 years) Children (2-9 years) Adolescents (10-18 years) Mumps Measles Rubella Varicella
NITAG recommendation Recommendation United States of America Diphtheria Tetanus Pertussis
Download:
Efficacy/effectiveness Safety Newborn (0-1 years) Children (2-9 years) Hepatitis B Diphtheria Tetanus Pertussis Poliomyelitis
Efficacy/effectiveness Safety Administration Newborn (0-1 years) Children (2-9 years) Adolescents (10-18 years) Mumps Measles Rubella
health policy Nepal Rotavirus
Download:
health policy Agenda & Minutes Kyrgyzstan Rotavirus
Download:
health policy Nepal Rotavirus
Download:
Recommendation Luxembourg Rabies
Download: